A. Sorete Arbore (Iasi, Romania), T. Aksamit (Rochester, Mn, United States of America)
Protective effect of N-acetylcysteine on anti tuberculosis drug-induced hepatotoxicity
S. Baniasadi, P. Eftekhari, P. Tabarsi, M. R. Raoufy, M. R. Masjedi (Tehran, Islamic Republic Of Iran)
|   |
Active tuberculosis with abnormal liver fonctions tests
S. Yaacoub, D. Hafaoua, M. Samira, B. M. Sonia, T. Fatma (Ariana, Tunisia)
| |
Side-effect in the treatment of pulmonary tuberculosis by first-line drugs
N. Antonava, A. Skrahina (Minsk, Belarus)
| |
Is pyrazinamide really hepatotoxic? A study of tuberculous patients with hepatotoxicity in Bahawal Victoria hospital, Bahawalpur
M. Ashraf, E. Ullah (Bahawalpur, Pakistan)
| |
Isoniazid plasma concentration monitoring in patients with pulmonary tuberculosis at a teaching referral hospital
S. Baniasadi, F. Fahimi, F. Kobarfard, P. Tabarsi, J. Salamzadeh, S. Hemati (Tehran, Islamic Republic Of Iran)
| |
Quantification of long term uptake and metabolism of isoniazid in patients treated for Mycobacterium tuberculosis infection
M. Eisenhut, S. Fieseler, H. Sachs, D. Schmid, D. Thieme (Luton, United Kingdom; Munich, Kreischa, Germany)
| |
Adverse reactions to antituberculosis chemotherapy: tolerance versus intolerance
V. Tudorache, R. Potre Oncu, S. Mihaicuta, V. Mihaiescu (Timisoara, Romania)
| |
Pulmonary TB -diabetes melitus – an unfavorable association
A. I. Dinescu, A. Dinescu, M. Popescu-Hagen, A. Corbu, C. Marica (Bucharest, Romania)
| |
Diabetes, glycemic control and risk of tuberculosis: a population-based case-control study
A. Leegaard, A. Riis, J. B. Kornum, C. R. Horsburgh, H. T. Sørensen, R. W. Thomsen (Aalborg, Denmark; Boston, United States Of America)
| |
Estimation of the risk of tuberculosis among people with diabetes
G. Marks, C. Dobler, J. Flack (Sydney, Australia)
| |
Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2?
P. Tabarsi, Z. Shariat, A. Faghani, M. Kazempour, M. R. Masjedi, D. Mansoori (Tehran, Islamic Republic Of Iran)
| |
The relation between radiological extent and serum lipid parameters,total protein, albumin and body mass index in patients with pulmonary tuberculosis
F. Sahin, D. Görgün, M. Bayraktaroglu, S. Eyhan, P. Yildiz (Zeytinburnu, Turkey)
| |
Elevated chitotriosidase levels in patient with pumonary tuberculosis: correlation with radiologic extent and degree of smaer positiviy
G. Subasi, E. Tozkoparan, E. Ucar, S. Gumus, E. O. Akgul, O. Deniz, I. Kurt, H. Bilgic (Bitlis, Ankara, Turkey)
| |
Candidosis due to treatment pulmonary diseases
Z. Lavor, N. Antonava, E. Nikolenko (Minsk, Belarus)
| |
A rarely seen side effect of anti-tuberculotics: lichen planus
B. Gebesoglu, S. Sahin, S. N. Kalaç, S. Artantas (Ankara, Turkey)
| |
Respiratory tuberculosis in lung cancer patients
J. Bento, A. P. Vaz, P. Mota, F. Coelho, H. Gonçalves, A. Adelina, C. Damas, T. Guimaraes, H. Queiroga, V. Hespanhol (Oporto, Portugal)
| |
When tuberculosis mimics lung cancer
H. Ramos, J. Dionisio, M. T. Almodovar, P. Ferreira, D. Matias, P. Mota, J. Duro da Costa (Lisboa, Faro, Portugal)
| |
Comorbidities – risk factors for relapsed pulmonary TB
M. Popescu-Hagen, M. Mihailescu, D. Bica, C. Didilescu, M. Tanasescu, B. Mahler, C. Marica (Bucharest, Craiova, Romania)
| |
Concomitant complicated meningitis with streptococcus pneumonia and mycobacterium tuberculosis
A. Crisan, V. Tudorache, S. Mihaicuta (Timisoara, Romania)
| |
Epidemiology of neurologic disorders in patients with pulmonology tuberculosis
Z. Kryvasheyeva, H. Hurevich, S. Lihachev, A. Ivashinko, T. Serenkova (Minsk, Belarus)
| |